154 related articles for article (PubMed ID: 20334660)
1. In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2.
Jeong KI; Chapman-Bonofiglio S; Singh P; Lee J; Tzipori S; Sheoran AS
BMC Immunol; 2010 Mar; 11():16. PubMed ID: 20334660
[TBL] [Abstract][Full Text] [Related]
2. Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody.
Krautz-Peterson G; Chapman-Bonofiglio S; Boisvert K; Feng H; Herman IM; Tzipori S; Sheoran AS
Infect Immun; 2008 May; 76(5):1931-9. PubMed ID: 18285498
[TBL] [Abstract][Full Text] [Related]
3. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Fab and F(ab')2 fragments and isotype variants of a recombinant human monoclonal antibody against Shiga toxin 2.
Akiyoshi DE; Sheoran AS; Rich CM; Richard L; Chapman-Bonofiglio S; Tzipori S
Infect Immun; 2010 Mar; 78(3):1376-82. PubMed ID: 20086088
[TBL] [Abstract][Full Text] [Related]
5. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants.
Sheoran AS; Chapman S; Singh P; Donohue-Rolfe A; Tzipori S
Infect Immun; 2003 Jun; 71(6):3125-30. PubMed ID: 12761090
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
[TBL] [Abstract][Full Text] [Related]
7. Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2.
Arimitsu H; Sasaki K; Iba Y; Kurosawa Y; Shimizu T; Tsuji T
Microbiol Immunol; 2015 Feb; 59(2):71-81. PubMed ID: 25521016
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.
Sheoran A; Jeong KI; Mukherjee J; Wiffin A; Singh P; Tzipori S
BMC Immunol; 2012 Jun; 13():27. PubMed ID: 22655967
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.
Akiyoshi DE; Rich CM; O'Sullivan-Murphy S; Richard L; Dilo J; Donohue-Rolfe A; Sheoran AS; Chapman-Bonofiglio S; Tzipori S
Infect Immun; 2005 Jul; 73(7):4054-61. PubMed ID: 15972493
[TBL] [Abstract][Full Text] [Related]
10. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
[TBL] [Abstract][Full Text] [Related]
11. Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects
Luz D; Amaral MM; Sacerdoti F; Bernal AM; Quintilio W; Moro AM; Palermo MS; Ibarra C; Piazza RMF
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30513821
[TBL] [Abstract][Full Text] [Related]
12. Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.
Sheoran AS; Chapman-Bonofiglio S; Harvey BR; Mukherjee J; Georgiou G; Donohue-Rolfe A; Tzipori S
Infect Immun; 2005 Aug; 73(8):4607-13. PubMed ID: 16040972
[TBL] [Abstract][Full Text] [Related]
13. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
Lu X; Skurnik D; Pozzi C; Roux D; Cywes-Bentley C; Ritchie JM; Munera D; Gening ML; Tsvetkov YE; Nifantiev NE; Waldor MK; Pier GB
mBio; 2014 Mar; 5(2):e00974-14. PubMed ID: 24667709
[TBL] [Abstract][Full Text] [Related]
14. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C
Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice.
Melton-Celsa AR; Carvalho HM; Thuning-Roberson C; O'Brien AD
Clin Vaccine Immunol; 2015 Apr; 22(4):448-55. PubMed ID: 25716230
[TBL] [Abstract][Full Text] [Related]
16. Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15.
Kimura T; Tani S; Motoki M; Matsumoto Y
Biochem Biophys Res Commun; 2003 Jun; 305(4):1057-60. PubMed ID: 12767937
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities.
Rocha LB; Luz DE; Moraes CT; Caravelli A; Fernandes I; Guth BE; Horton DS; Piazza RM
Toxins (Basel); 2012 Sep; 4(9):729-47. PubMed ID: 23105978
[TBL] [Abstract][Full Text] [Related]
18. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin type 2 B subunit protects mice against toxin challenge when leashed and bundled by a stable pentameric coiled-coil molecule.
Tamaki Y; Harakuni T; Arakawa T
Vaccine; 2024 Mar; 42(7):1757-1767. PubMed ID: 38365487
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
